Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy
Psoriatic patients with latent tuberculosis infection and properly treated active tuberculosis need careful management when prescribing modern biological drugs. Although data and guidelines regarding tumour necrosis factor-α inhibitors advise caution and initiation of prophylactic therapy in patient...
Main Authors: | Luca Mastorino, Paolo Dapavo, Mattia Trunfio, Gianluca Avallone, Marco Rubatto, Andrea Calcagno, Simone Ribero, Pietro Quaglino |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2022-11-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: | https://medicaljournalssweden.se/actadv/article/view/1982 |
Similar Items
-
Seven cancer patients receiving Guselkumab for treatment of moderate-to-severe psoriasis
by: Luca Mastorino, et al.
Published: (2022-03-01) -
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
by: Simone Ribero, et al.
Published: (2019-09-01) -
The Skin Microbiome and Its Role in Psoriasis: A Review
by: Celoria V, et al.
Published: (2023-10-01) -
Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
by: Elena Franchi, et al.
Published: (2023-12-01) -
Clinicoepidemiological study of childhood psoriasis in a tertiary care center
by: S G Suganya, et al.
Published: (2017-01-01)